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A B S T R A C T
Senior-Loken syndrome (SLS) is a rare disorder primarily associated with kidney and retinal dysfunction. We generated a human induced pluripotency stem cell
(hiPSC) line, designated DKHi005-A, from peripheral blood mononuclear cells of a patient with SLS using a Sendai virus reprogramming method. We confirmed that
DKHi005-A cells harbor the same mutation as the patient and show a normal karyotype. DKHi005-A also has pluripotency and the capacity for differentiation into the
three germ layers. This cell line is registered and available at the National Stem Cell Bank, Korea National Institute of Health.
Resource Table
Unique stem cell line i-
dentifier
DKHi005-A
Alternative name(s) of
stem cell line
DKH005i-A
Institution Korea National Institute of Health
Contact information of
distributor
Soo Kyung Koo, skkoo@nih.go.kr
Type of cell line iPSC
Origin Human
Additional origin info Applicable for human Ipsc
Age: 10
Sex: female
Ethnicity if known: Korean
Cell Source Peripheral blood mononuclear cells
Clonality Clonal
Method of reprogram-
ming
Transgene free Sendai virus (CytoTune™-iPS 2.0 Sendai
Reprogramming Kit, Thermo Fisher Scientific)
Genetic Modification Congenital
Type of Modification N/A
Associated disease Senior-Loken syndrome
Gene/locus NM 025132.3(WDR19): c.3533G>A/Chr4:
39274649(GRCh37)
Method of modification N/A
Name of transgene or r-
esistance
N/A
Inducible/constitutive s-
ystem
N/A
Date archived/stock da-
te
June 2018
Cell line repository/ba-
nk
Korea National Stem Cell Bank(KSCB)
Ethical approval Yonsei University Health System, Severance Hospital,
Institutional Review Board(IRB) approval obtained (IRB
No. 4-2016-1158)
IRB approval obtained (IRB No. 2017-03-05-C-A)
1. Resource utility
Senior-Loken syndrome(SLS) is rare and early-onset retinal dys-
trophy (Haghighi et al., 2011). This generated hiPSC line with a WDR19
R1178E mutation could facilitate investigations of the pathogenic me-
chanism underlying SLS and should serve as a valuable tool to screen
new drugs for improving the symptoms of SLS patients’.
2. Resource details
SLS accounts for less than 1% of all infantile-onset retinal dystro-
phies. However, patients presenting with early-onset retinal dystrophy
are not routinely screened for renal dysfunction. To date, six causative
genes of SLS have been reported, including WDR19, the least frequent
overall (Coussa et al., 2013). A recent study showed that eupatilin
rescued the ciliary transition zone defects from ameliorating ciliopathy-
related phenotypes in a mouse model (Kim et al., 2018); however, the
efficacy of eupatilin for SLS treatment needs to be confirmed in a hu-
manized model. Thus, we established an iPSC line from a patient with
SLS to serve as a retinal model. The patient, first presented at the clinic
at the age of 1 year with symmetric pendular nystagmus. She could fix
and follow objects, and cycloplegic refraction was +8.00 in both eyes.
Dilated fundus examination was normal at the posterior pole. At 2
years, she was admitted to hospital due to dyspnea and fever. Blood
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urea nitrogen was 95 mg/dL (normal: 7–17 mg/dL) and the serum
creatinine level was 4.3 mg/dL (normal: 0.68–1.19 mg/dL). Hemodia-
lysis was performed, and the ultrasonogram showed poor corticome-
dullary differentiation of both kidneys with high echogenicity of the
parenchyma. Intrahepatic duct dilation and splenomegaly were also
noted. A diagnosis of nephronophthisis was made, and she was re-
evaluated for possible retinal involvement. Dilated fundus examination
showed a depigmented patch-like lesion at the temporal to the macula.
At the age of 2 years and 6 months, living-donor kidney transplantation
from her mother and liver transplantation from a deceased donor were
Fig. 1. Characterization of DKHi005-A cell line.
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performed. At the age of 7 years, dilated fundus examination showed
diffuse pigmentary retinopathy and optic atrophy. Her best visual
acuity was 20/400 in both eyes. Full-field electroretinogram showed
extinguished responses. Targeted panel next-generation sequencing
revealed a homozygous c.3533G>A (p.Arg1178Glu) WDR19 mutation.
The patient's peripheral blood mononuclear cells (PBMCs) were re-
programmed into DKHi005-A using a Sendai virus-based gene delivery
system. The morphology of DKHi005-A cells was similar to that of ty-
pical human embryonic stem cells (Fig. 1A). G-banding analysis ex-
hibited a normal karyotype (46, XX) in the DKHi005-A hiPSC line
(Fig. 1B). The DKHi005-A hiPSC line was reverse-transcribed using
reprogramming factor-targeted primers, demonstrating that all factors
to induce reprogramming were silenced (Fig. 1C). The pluripotency of
the generated hiPSC line was identified by immunocytochemistry
staining with pluripotency markers OCT4, SSEA4, Tra-1-60, and Tra-1-
81 (Fig. 1D). We also identified pluripotency at the mRNA level with
Taqman® Expression Probes based on the embryonic stem cell line H9
(Fig. 1E). The DKHi005-A hiPSC line harbors the same G3533A
homozygous mutation confirmed in the patient (Fig. 1F). Embryonic
body formation assessment (Fig. 1G) demonstrated that DKHi005-A
hiPSC line expressed all three germ layer markers, PAX6 (ectoderm), T
(medoderm) and HNF3-β (endoderm), using Taqman® Expression
Probes (Fig. 1H). Short tandem repeat (STR) analysis showed that 16
allele loci of DKHi005-A were consistent with those of donor cells.
Detailed information on STR analysis is presented in the supplementary
data. DKHi005-A was confirmed to be free from Mycoplasma infection
(Supplementary Fig. S1)(Table 1).
3. Materials and methods
3.1. Reprogramming and hiPSC maintenance
Human iPSCs were generated by reprogramming PBMCs using a
CytotuneiPS™-iPS 2.0 Sendai Reprogramming Kit (Life Technologies)
following the manufacture's protocol (Fusaki et al., 2009). Obtained
clones were cultured onto vitronectin (Gibco) coated plates with
TeSR™-E8™ medium (Stemcell Technologies). The culture medium was
changed every day.
3.2. Karyotyping
The cultured cells were treated with colcemid for 45 min and then
harvested in hypotonic solution with fixative, followed by the pre-
paration of metaphase slides. After Giemsa-trypsin banding, the kar-
yotype was analyzed according to the International System for Human
Cytogenetic Nomenclature using the standard GTG-banding method.
3.3. Detection of the reprogramming vector
Total RNA was isolated using a Maxwell® RSC simplyRNA Cells Kit
(Promega), and cDNA was synthesized by reverse transcription using
RNA to cDNA EcoDry Premix (Clontech). hiPSCs at passage 2 were used
as a positive control. Glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) was amplified concurrently and used as an internal control. A
negative control was included in all runs with all of the same compo-
nents except the template to detect contamination with nucleic acids.
3.4. Mutation sequencing
Genomic DNA was isolated using a Maxwell® RSC Blood DNA Kit
(Promega) and sent for Cosmogenetech (Seoul, Korea) with designed
primers. The control cell line is the KSCBi002-B which is already re-
gistered in the hPSCreg.
3.5. Immunocytochemistry
Cells were fixed with 4% paraformaldehyde (Wako) for 20 min,
blocked with 5% bovine serum albumin (Sigma-Aldrich) with 0.25%
Triton X (Sigma-Aldrich), and incubated with primary antibodies for
Oct3/4, SSEA4, Tra-1-60, and Tra-1-81 (Table 2). Images were acquired
using a fluorescence microscope (scale bar: 20 µm).
3.6. Real-time PCR analysis
Real-time PCR was performed using Taqman® Gene Expression
Master Mix (Applied Biosystems). All quantitative gene expressions
were normalized to the expression level of GAPDH. The probes used are
listed in Table 2.
3.7. In vitro differentiation into the three germ layers
To determine the capacity of the hiPSCs to differentiate into the
three germ layers, we induced embryoid bodies using hiPSCs harvested
by dispase (Gibco). The culture medium for embryoid bodies was
DMEM/F12 (Gibco) supplemented with 20% Knockout Serum
Replacement (Gibco), 0.1 mol/L Minimal Essential Media non-essential
amino acids solution (Gibco), 0.1 mmol/L 2-mercaptoethanol (Gibco),
1% (v/v) penicillin-streptomycin (Gibco) and MycoZap plus-PR
(Lonza). The culture medium was changed every other day. The em-
bryoid bodies were harvested at 14 days and real-time PCR analysis for
the three germ layers was performed. The probes used are listed in
Table 2.
Table 1
Characterization and validation.
Classification Test Result Data
Morphology Photography Normal Fig. 1 panel A
Phenotype Immunocytochemistry OCT4, SSEA4, Tra-1-60 and Tra-1-81 Fig. 1 panel D
Real-time PCR NANOG, OCT4, SOX2, TERT, TDGF1, DNMT3B, GABRB3, GDF3 and
REX1
Fig. 1 panel E
Genotype Karyotype (G-banding) and resolution 46XX, Resolution 500 Fig. 1 panel B
Identity Microsatellite PCR (mPCR) OR STR
analysis
Not performed Not performed
Tested 16 loci, all matched STR analysis
Mutation analysis (IF
APPLICABLE)
Sequencing Homozygous Fig. 1 panel F
Southern Blot OR WGS Not performed Not performed
Microbiology and virology Mycoplasma Mycoplasma testing by RT-PCR negative Supplementary figure 1
Differentiation potential Embryoid body formation Paired box 6 (PAX6) for ectoderm, Brachyury (T) for mesoderm and
Hepatocyte nuclear factor-3 beta (HNF-3β) for endoderm
Fig. 1 panel G and H
Donor screening (OPTIONAL) HIV 1 + +2 Hepatitis B, Hepatitis C Not performed Not performed
Genotype additional info
(OPTIONAL)
Blood group genotyping Not performed Not performed
HLA tissue typing Not performed Not performed
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3.8. STR analysis
STR analysis of the generated hiPSCs and parental cells was per-
formed using a PowerPlex 16 System (Promega) to detect 16 loci.
3.9. Mycoplasma test
The Mycoplasma test of the cell culture medium was performed
using a PCR Mycoplasma Detection Set (TAKARA).
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Table 2
Reagents details.
RRID Requirement for antibodies: use http://antibodyregistry.org/ to retrieve RRID for antibodies and include ID in table as shown in examples.
Antibodies used for immunocytochemistry/flow-citometry
Antibody Dilution Company Cat # and RRID
Pluripotency Marker Rabbit anti-OCT3/4 1:200 Santa Cruz Biotechnology Cat# sc-9081, RRID:AB_2167703
Pluripotency Marker Mouse anti-SSEA4 1:200 Millipore Cat# MAB4304, RRID:AB_177629
Pluripotency Marker Mouse anti-TRA-1-60 1:200 Millipore Cat# MAB4360, RRID:AB_2119183
Pluripotency Marker Mouse anti-TRA-1-81 1:200 Millipore Cat# MAB4381, RRID:AB_177638
Secondary antibody Anti-rabbit IgG(H+L) Fluorescein conjugated 1:500 Vector Laboratories Cat# FI-1000, RRID:AB_2336197
Secondary antibody Anti-mouse IgG(H+L) Fluorescein conjugated 1:500 Vector Laboratories Cat# FI-2000, RRID:AB_2336176
Primers
Target Forward/Reverse primer (5′-3′)
Sendai virus test(RT-PCR) SeV GGATCACTAGGTGATATCGAGC/ ACCAGACAAGAGTTTAAGAGATATGTATC
Sendai virus test(RT-PCR) KOS ATGCACCGCTACGACGTGAGCGC/ACCTTGACAATCCTGATGTGG
Sendai virus test(RT-PCR) Klf4 TTCCTGCATGCCAGAGGAGCCC/AATGTATCGAAGGTGCTCAA
Sendai virus test(RT-PCR) c-Myc TAACTGACTAGCAGGCTTGTCG/TCCACATACAGTCCTGGATGATGATG
Targeted mutation analysis/sequencing 3533G>A GGCCATCATCAAGGAGTTGT/GGGTGAGAGCTCTGGTCAGT
House-Keeping Gene(RT-PCR) GAPDH CATGTTCGTCATGGGTGTGAA/GGACTGTGGTCATGAGTCCTT
Pluripotency Marker (qPCR) NANOG Hs02387400-g1 (Taqman® probe ID)
Pluripotency Marker (qPCR) OCT4 Hs00742896-s1 (Taqman® probe ID)
Pluripotency Marker (qPCR) SOX2 Hs00602736-s1 (Taqman® probe ID)
Pluripotency Marker (qPCR) TERT Hs00162669-m1 (Taqman® probe ID)
Pluripotency Marker (qPCR) TDGF1 Hs02339499-g1 (Taqman® Probe ID)
Pluripotency Marker (qPCR) DNMT3B Hs00171876-m1 (Taqman® Probe ID)
Pluripotency Marker (qPCR) GABRB3 Hs00241459-m1 (Taqman® Probe ID)
Pluripotency Marker (qPCR) GDF3 Hs00220998-m1 (Taqman® Probe ID)
Pluripotency Marker (qPCR) REX1 Hs00399279-m1 (Taqman® Probe ID)
Differentiation Marker (qPCR) PAX6 Hs00240871-m1 (Taqman® Probe ID)
Differentiation Marker (qPCR) T (Brachyury) Hs00610080-m1 (Taqman® Probe ID)
Differentiation Marker (qPCR) HNF-3β Hs00232764-m1 (Taqman® Probe ID)
House-Keeping Gene (qPCR) GAPDH Hs999999905-m1 (Taqman® Probe ID)
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